+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Newborn Screening Market by Technology, Test Type, End User, Sample Type - Global Forecast to 2030- Product Image
Newborn Screening Market by Technology, Test Type, End User, Sample Type - Global Forecast to 2030- Product Image
Sale

Newborn Screening Market by Technology, Test Type, End User, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674209
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Newborn Screening Market is transforming preventive healthcare, driven by rapid advancements in diagnostic technologies, evolving regulations, and increased focus on early intervention. Senior decision-makers seeking to streamline workflows and secure a competitive edge benefit from a clear perspective on how innovation and policy shifts are reshaping the sector.

Market Snapshot: Newborn Screening Market Trends

The Newborn Screening Market grew from USD 1.06 billion in 2024 to USD 1.16 billion in 2025. It is expected to continue growing at a CAGR of 8.83%, reaching USD 1.76 billion by 2030. Demand is fueled by heightened awareness, robust public health initiatives, and integration of sophisticated genetic screening methods. The market reflects consistent global expansion with opportunities tied to next-generation sequencing, digital health integration, and optimized supply chains despite challenges in regional rollouts and regulatory requirements.

Scope & Segmentation

This research provides targeted analysis of the newborn screening market by technology, test type, end user, sample type, regions, and key players. Each segmentation gives stakeholders actionable insight into growth areas and operational challenges.

  • Technologies: High Performance Liquid Chromatography, Immunoassay, Molecular Techniques including Polymerase Chain Reaction and Sanger Sequencing, Next Generation Sequencing, Tandem Mass Spectrometry.
  • Test Types: Cystic Fibrosis, Endocrine Disorders, Hemoglobin Disorders, Inborn Errors Of Metabolism.
  • End Users: Diagnostic Laboratories, Hospitals and Clinics, Research Laboratories.
  • Sample Types: Dried Blood Spot, Serum Sample.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Players: PerkinElmer, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Waters Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., BioMérieux SA, Siemens Healthineers AG, Shimadzu Corporation.

Key Takeaways for Senior Decision-Makers

  • Molecular diagnostics and next-generation sequencing are moving from specialized research to standard clinical practice, broadening the detection of rare and complex disorders.
  • Digital health innovations such as cloud data management and AI-driven analytics are shortening turnaround times and enhancing data quality, encouraging wider adoption and expansion of screening panels.
  • Regional dynamics play a key role; while North America and Western Europe lead with advanced infrastructure and broad coverage, growth in Asia-Pacific is accelerated by government mandates and capacity-building collaborations.
  • Supply chain resilience is a growing priority. Procurement strategies now favor pooled purchasing, domestic manufacturing alliances, and dual-supplier models to mitigate risks from geopolitical or tariff disruptions.
  • Collaborations between diagnostic companies, software developers, and contract research organizations are creating comprehensive service bundles, reducing capital barriers for smaller healthcare systems and driving interconnected value chains.

Tariff Impact: Shaping Cost Structures and Supply Chains

Recent U.S. tariffs on imported diagnostic reagents and equipment have elevated procurement costs and extended lead times for laboratories relying on international suppliers. This has prompted swift shifts in procurement toward domestic and regional manufacturing, as well as pooling of orders and collaborative purchasing at larger scales. In the short term, these tariffs contribute to increased operating expenses, while in the long term, they drive investment in more agile, resilient, and efficient supply infrastructures across the newborn screening market.

Methodology & Data Sources

The market analysis integrates exhaustive secondary research, including peer-reviewed articles and regulatory filings, with targeted primary interviews among laboratory directors, clinicians, procurement specialists, and industry analysts. Quantitative data is cross-validated for consistency, and detailed data normalization ensures reliable market segmentation and trend identification.

Why This Report Matters

  • Enables informed strategic planning by equipping leaders with actionable insights into evolving technology, reimbursement trends, and emerging regional hotspots.
  • Supports risk mitigation by detailing supply chain adaptations and key partnerships essential for navigating regulatory and geopolitical uncertainties.
  • Empowers investment prioritization by highlighting the operational realities driving adoption of new screening methods and infrastructure modernization.

Conclusion

The newborn screening market is evolving with rapid advances in molecular and digital diagnostics and adaptive procurement strategies. For senior leaders, aligning technology, operational resilience, and regional engagement is key to achieving sustainable advantages and expanded patient impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Newborn Screening Market, by Technology
8.1. Introduction
8.2. High Performance Liquid Chromatography
8.3. Immunoassay
8.4. Molecular Techniques
8.4.1. Polymerase Chain Reaction
8.4.2. Sanger Sequencing
8.5. Next Generation Sequencing
8.6. Tandem Mass Spectrometry
9. Newborn Screening Market, by Test Type
9.1. Introduction
9.2. Cystic Fibrosis
9.3. Endocrine Disorders
9.4. Hemoglobin Disorders
9.5. Inborn Errors of Metabolism
10. Newborn Screening Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals and Clinics
10.4. Research Laboratories
11. Newborn Screening Market, by Sample Type
11.1. Introduction
11.2. Dried Blood Spot
11.3. Serum Sample
12. Americas Newborn Screening Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Newborn Screening Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Newborn Screening Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. PerkinElmer, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Danaher Corporation
15.3.4. Agilent Technologies, Inc.
15.3.5. Waters Corporation
15.3.6. Abbott Laboratories
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. BioMérieux SA
15.3.9. Siemens Healthineers AG
15.3.10. Shimadzu Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEWBORN SCREENING MARKET MULTI-CURRENCY
FIGURE 2. NEWBORN SCREENING MARKET MULTI-LANGUAGE
FIGURE 3. NEWBORN SCREENING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEWBORN SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEWBORN SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEWBORN SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEWBORN SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEWBORN SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEWBORN SCREENING MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEWBORN SCREENING MARKET SIZE, BY ENDOCRINE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HEMOGLOBIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEWBORN SCREENING MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEWBORN SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEWBORN SCREENING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEWBORN SCREENING MARKET SIZE, BY SERUM SAMPLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. CANADA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 41. CANADA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. MEXICO NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 46. MEXICO NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. GERMANY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. GERMANY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 72. GERMANY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. GERMANY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 75. FRANCE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. FRANCE NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 77. FRANCE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. FRANCE NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 85. ITALY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. ITALY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 87. ITALY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. ITALY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ITALY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 90. SPAIN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. SPAIN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 92. SPAIN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. SPAIN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 112. DENMARK NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. DENMARK NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. QATAR NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 122. QATAR NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. QATAR NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. QATAR NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 125. FINLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. FINLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 127. FINLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FINLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. EGYPT NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 142. EGYPT NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EGYPT NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 145. TURKEY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. TURKEY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 147. TURKEY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. TURKEY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 155. NORWAY NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. NORWAY NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 157. NORWAY NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. NORWAY NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. POLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. POLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 162. POLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. POLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. POLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC NEWBORN SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. CHINA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. CHINA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 178. CHINA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. CHINA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. CHINA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. INDIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 183. INDIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. INDIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. JAPAN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. JAPAN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 188. JAPAN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. JAPAN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 206. THAILAND NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. THAILAND NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 208. THAILAND NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. THAILAND NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN NEWBORN SCREENING MARKET SIZE, BY MOLECULAR TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN NEWBORN SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 236. NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 237. NEWBORN SCREENING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Newborn Screening market report include:
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Waters Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • BioMérieux SA
  • Siemens Healthineers AG
  • Shimadzu Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.16 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.76 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Newborn Screening - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Newborn Screening - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032 - Product Image

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Newborn Screening - Global Strategic Business Report - Product Image

Newborn Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Newborn Screening Market: Analysis By Product, By Technology, By Test Type, By End User, By Region Size and Trends and Forecast up to 2029 - Product Image

Newborn Screening Market: Analysis By Product, By Technology, By Test Type, By End User, By Region Size and Trends and Forecast up to 2029

  • Report
  • 152 Pages
  • Global
From
Newborn Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Newborn Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.